H. Direskeneli Et Al. , "Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease.," Clinical rheumatology , vol.27, no.3, pp.373-5, 2008
Direskeneli, H. Et Al. 2008. Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease.. Clinical rheumatology , vol.27, no.3 , 373-5.
Direskeneli, H., Ergun, T., Yavuz, S., Hamuryudan, V., & Eksioglu-Demiralp, E., (2008). Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease.. Clinical rheumatology , vol.27, no.3, 373-5.
Direskeneli, RAFİ Et Al. "Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease.," Clinical rheumatology , vol.27, no.3, 373-5, 2008
Direskeneli, RAFİ H. Et Al. "Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease.." Clinical rheumatology , vol.27, no.3, pp.373-5, 2008
Direskeneli, H. Et Al. (2008) . "Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease.." Clinical rheumatology , vol.27, no.3, pp.373-5.
@article{article, author={RAFİ HANER DİRESKENELİ Et Al. }, title={Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease.}, journal={Clinical rheumatology}, year=2008, pages={373-5} }